Weight-loss drugmakers seek Medicare coverage and challenge diet charlatans.
TL;DR
The author expresses anger towards the food industry and diet peddlers for creating a system that makes it difficult for people to lose weight. The article discusses the potential benefits of GLP-1 agonist weight-loss drugs, which mimic a hormone that reduces appetite. The author argues that these drugs could be a game-changer for people struggling with weight loss and could put diet peddlers out of business. However, the author acknowledges the need to address issues of access and affordability for long-term success.
Topics:businesshealth#diet-industry#food-environment#glp-1-agonists#health#obesity#weight-loss-drugs
- Perspective | Will weight-loss drugs put diet charlatans out of business? I hope so. The Washington Post
- Weight-Loss Drugmakers Lobby for Medicare Coverage The Wall Street Journal
- Weight-loss drugmakers push for Medicare coverage (NYSE:LLY) Seeking Alpha
- Pharmalittle: Weight-loss drug makers lobby Congress for Medicare coverage; Europe braces for new pharma legislation STAT
- View Full Coverage on Google News
Want the full story? Read the original reporting
Read on The Washington Post